605116.SHG Aurisco Pharmaceutical Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
18.78 CNY
Close of Nov 5, 2026
16.66 34.98
Market cap
CNY 7.63B
P/E
24.4x
P/B
2.70x
ROE
11.9%
Dividend yield
1.63%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 605116.SHG undervalued?

Graham number
Price18.78
Graham value10.97
Premium71.2%

605116.SHG trades 71.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aurisco Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Aurisco Pharmaceutical Co Ltd yet.

Aurisco Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aurisco Pharmaceutical Co Ltd

Aurisco Pharmaceutical Co.,Ltd. engages in the research, development, production and sales of special complex APIs, pharmaceutical intermediates and preparations worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides eplerenone, an API to treat cardiovascular diseases, lowering blood pressure, and treating heart failure; futicasone propionate, used for …

Full company profile